LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

24,24-difluoro-26,27-dimethylvitamin D.sub.3 derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

24-and 25-substituted avermectin and milbemycin derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

24-cyclopropane vitamin D derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

24-homo vitamin D derivatives, process for their production and

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

24-hydroxyvitamin D, analogs and uses thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

24-hydroxyvitamin D, analogs and uses thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

24-Oxa derivatives in the vitamin D series

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

24-sulfoximine vitamin D 3 compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

24-sulfoximine vitamin D3 compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

24-Sulfur-substituted analogs of 1α,25-dihydroxy...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

24R,25-dihydroxycholecalciferol to treat vitamin D resistant ric

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

25, 28-dihydroxyergocalciferol and 1,25,28-trihydroxyergocalcife

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

25,26-Dehydro-1.alpha.,23(S,R)-dihydroxycholecalciferol and its

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

25,26-dehydro-1.alpha.,24R-dihydroxycholecalciferol and 25,26-de

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

25-Carboxylic acid derivatives in the vitamin D series, process

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Food or edible as carrier for pharmaceutical

25-hydroxy vitamin D 3 compositions

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

25-Hydroxycalciferol compounds for treatment of steroid-induced

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

25S,26-dihydroxycholecalciferol in the treatment of hypercalcitr

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

26,26,26,27,27-pentafluoro-1.alpha.-hydroxy-27-methoxyvitamin D.